BACKGROUND: Alcohol-associated hepatitis (AH) has a short-term mortality rate of up to 40% primarily related to impaired hepatocyte regeneration and uncontrolled liver inflammation. The acute phase protein fibrinogen-like protein 1 (FGL-1) produced by hepatocytes stimulates hepatocyte proliferation by autocrine signaling. FGL-1 also is a ligand for the inhibitory T cell receptor lymphocyte activation gene 3 (LAG-3). In these ways, FGL-1 and LAG-3 have beneficial interactions that could be interrupted in AH. AIMS: We aimed to characterize FGL-1 and LAG-3 in patients with AH and describe their relationship with the disease state and course. METHODS: Thirty-two patients with AH were included at diagnosis and followed up for 3 years. We measured the hepatic gene expression of FGL-1 and LAG-3 using RNA sequencing, plasma FGL-1 and soluble (s)LAG-3 using ELISA, and LAG-3(+)CD8(+) T cells using flow cytometry. Healthy persons (HC) and patients with stable alcohol-associated cirrhosis served as controls. RESULTS: At diagnosis of AH, liver FGL-1 mRNA was increased when compared to HC, whereas plasma FGL-1 was unchanged. In contrast, liver LAG-3 mRNA was reduced in AH. Plasma sLAG-3 levels and the frequency of LAG-3(+)CD8(+) T cells were as in HC. However, those patients who had the lowest plasma FGL-1 and the lowest frequency of LAG-3(+)CD8(+) T cells at diagnosis had the highest disease severity and mortality. CONCLUSIONS: Our data suggest that an impaired FGL-1/LAG-3 axis may be involved in the pathogenesis and course of AH.
The FGL-1/LAG-3 Axis is Associated With Disease Course in Alcohol-associated Hepatitis: A Preliminary Report.
FGL-1/LAG-3 轴与酒精相关性肝炎的疾病进程相关:初步报告
阅读:6
作者:Pedersen Lasse, Eriksen Lotte L, Brix Frederik H, Vilstrup Hendrik, Deleuran Bent, Sandahl Thomas D, Støy Sidsel
| 期刊: | Journal of Clinical and Experimental Hepatology | 影响因子: | 3.200 |
| 时间: | 2025 | 起止号: | 2025 Jan-Feb;15(1):102424 |
| doi: | 10.1016/j.jceh.2024.102424 | 研究方向: | 免疫/内分泌 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
